Compare Lithium Americas Corp (LAC) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lithium Americas Corp vs Novo Nordisk A/S — how do they compare? Lithium Americas Corp trades at $3.08 (market cap $1.01B), while Novo Nordisk A/S trades at $49.35 (market cap $220.53B). The key difference: Novo Nordisk A/S is far larger — about 218.3× Lithium Americas Corp's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals.
| LAC | NVO | |
|---|---|---|
Market Cap | $1.01B | $220.53B |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $71.70 |
52-Week Low | $2.55 | $35.29 |
Enterprise Value | $1.13B | $239.49B |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
